| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
N/A |
| Shares
Out: |
19,300,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$57.98 - $57.98 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schuermann James |
SVP, Sales & Marketing |
• – – |
2013-08-01 |
4 |
AS |
$93.07 |
$93,070 |
D/D |
(1,000) |
4,171 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-08-01 |
4 |
AS |
$93.06 |
$202,888 |
D/D |
(2,179) |
16,164 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-08-01 |
4 |
OE |
$15.77 |
$34,363 |
D/D |
2,179 |
18,343 |
|
- |
|
| Larkin C Raymond Jr |
Director |
– • – |
2013-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
564 |
4,000 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-07-29 |
4 |
AS |
$92.08 |
$693,846 |
D/D |
(7,530) |
65,977 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-07-29 |
4 |
OE |
$35.63 |
$90,144 |
D/D |
2,530 |
73,507 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-07-26 |
4 |
AS |
$92.64 |
$1,191,323 |
D/D |
(12,834) |
70,977 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-07-26 |
4 |
OE |
$35.32 |
$453,297 |
D/D |
12,834 |
83,811 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-07-25 |
4 |
AS |
$93.45 |
$1,182,293 |
D/D |
(12,636) |
70,977 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-07-25 |
4 |
OE |
$35.53 |
$448,957 |
D/D |
12,636 |
83,613 |
|
- |
|
| Mcaree Peter F |
SVP, CFO and Treasurer |
• – – |
2013-07-10 |
4 |
AS |
$93.58 |
$276,061 |
D/D |
(2,950) |
3,300 |
|
- |
|
| Mcaree Peter F |
SVP, CFO and Treasurer |
• – – |
2013-07-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-07-01 |
4 |
AS |
$95.65 |
$208,866 |
D/D |
(2,179) |
16,164 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-07-01 |
4 |
OE |
$15.98 |
$34,820 |
D/D |
2,179 |
18,343 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2013-07-01 |
4 |
S |
$95.29 |
$1,253,734 |
D/D |
(13,118) |
140,302 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2013-06-26 |
4 |
AS |
$95.00 |
$94,240 |
D/D |
(992) |
3,611 |
|
- |
|
| Yocher Robert E |
SVP, Regulatory & Quality |
• – – |
2013-06-25 |
4 |
AS |
$94.25 |
$109,519 |
D/D |
(1,162) |
3,352 |
|
- |
|
| Yocher Robert E |
SVP, Regulatory & Quality |
• – – |
2013-06-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
4,514 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-06-17 |
4 |
AS |
$91.14 |
$198,594 |
D/D |
(2,179) |
16,164 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-06-17 |
4 |
OE |
$16.74 |
$36,476 |
D/D |
2,179 |
18,343 |
|
- |
|
| Thomas Robert Bain |
Director |
– • – |
2013-06-06 |
4 |
S |
$89.57 |
$240,200 |
I/I |
(2,656) |
6,942 |
|
- |
|
| Thomas Robert Bain |
Director |
– • – |
2013-05-30 |
4 |
S |
$94.05 |
$5,361 |
I/I |
(57) |
8,228 |
|
- |
|
| Thomas Robert Bain |
Director |
– • – |
2013-05-29 |
4 |
S |
$92.83 |
$66,300 |
I/I |
(714) |
8,285 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2013-05-28 |
4 |
S |
$95.05 |
$564,027 |
D/D |
(5,934) |
0 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2013-05-28 |
4 |
OE |
$19.22 |
$86,317 |
D/D |
4,491 |
5,934 |
|
- |
|
776 Records found
|
|
Page 12 of 32 |
|
|
